Xontogeny

Xontogeny is a biotech aggregator founded in 2016, with a mission to support the accelerated development of life science technologies to aid patients with serious diseases. The company partners with entrepreneurs, providing leadership and operating experience to increase the probability of success with early drug and technology development. Xontogeny holds the belief that scientific founders are crucial to the success of their companies, and focuses on supporting the entrepreneur's pursuit and optimizing the development pathway with an exceptionally talented and experienced operational team. The company's last investment of $15.00M in a Series A round on 18 May 2017 was secured from Perceptive Advisors, reflecting investor confidence in Xontogeny's innovative approach. With a focus on Biopharma, Biotechnology, Health Care, and Information Technology, the United States-based company's dynamic model not only supports the goals of the founding scientists and entrepreneurs to retain more control and equity but also increases the chance of accessing investment and, ultimately, development success.